New Trial CABOGIST now open
Cabozantinib in patients with metastatic gastrointestinal stromal tumor (GIST) who progressed during neoadjuvant, adjuvant or palliative therapy with imatinib and sunitinib.
Trial name: CABO-GIST (see more information on our study registry)
Status: Open, recruiting
Sponsor: European Organisation for Research and Treatment of Cancer – EORTC
Further information https://clinicaltrials.gov/ct/show/NCT02216578 or http://www.eortc.org/clinical-trials/
Leave a Comment